Clinical Cancer Drugs Identified As Inhibitors Of Inflammatory Signaling
Imatinib (sold as Gleevec) is a breakthrough cancer drug approved in 2001 for the treatment of Chronic Myeloid Leukaemia (CML). It was designed to inhibit…
Read more










